Skip to main content
Caplight Logo









Transit Therapeutics, Inc.

Transit Therapeutics, Inc.

Private
Woodside, CaliforniaHealthcare & Life Scienceshttps://transittx.com/

Company Overview

Transit Therapeutics, Inc. is a biotechnology company that develops protein-free trans-splicing of pre-mRNA to create therapeutic treatments for genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

trans-splicingpre-mRNAgenetic medicineRNA therapeuticsgene therapyCNS therapeuticsbiotech licensinggenomic integrationdrug discoveryprecision medicinebiotech startupstealth biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Transit Therapeutics, Inc. Comparables

Compare Transit Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Transit Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tacit Therapeutics
87%
Ascidian Therapeutics
81%
Amber Bio
79%

Transit Therapeutics, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Transit Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Transit Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Transit Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWoodside, California
Year Founded2025
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?